Mm. Garcia et Re. Harlan, CHRONIC MORPHINE INCREASES CALBINDIN D-28K IN RAT STRIATUM - POSSIBLENMDA RECEPTOR INVOLVEMENT, NeuroReport, 5(1), 1993, pp. 65-68
THE neuronal intracellular calcium-binding protein calbindin D-28k is
a neurochemical marker in the striatum. normally expressed in the matr
ix compartment and absent from the mu-opiate receptor-enriched strioso
mal (patch) compartment. Because chronic treatment with morphine has b
een reported to increase calcium levels in synaptosomes of rat striatu
m, we studied effects of morphine on calbindin immunoreactivity (ir) i
n rat brain, using immunocytochemistry. Treatment with morphine for 5
days increased calbindin-ir in the striatal matrix, and induced intens
e calbindin-ir in the patch compartment. Increased calbindin-ir in pat
ches persisted through day 14 post-morphine. Co-administration of the
NMDA receptor antagonist MK-801 blocked the morphine-induced increase
in calbindin-ir in patches. We suggest that chronic morphine treatment
may increase calcium and calbindin levels via increased glutamatergic
transmission in striatum. These findings are consistent with reports
that MK-801 inhibits tolerance to morphine, and provide a possible mec
hanism and anatomical substrate for this inhibition.